The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Validation Services Market Research Report 2024
Synopsis
The global Pharmaceutical Validation Services market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 133.6 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Validation Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Validation Services.
Report Scope
The Pharmaceutical Validation Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Validation Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Validation Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbor Group
ATS Global
Catalent
CRS Pharma Solutions
Eurofins Scientific
Körber Pharma
Merck Millipore
MTS (Meissner Technical Services)
Navitas pharma READY
PharmOut
SGS
Sigma-Aldrich
SL Controls
Transcat
Segment by Type
Pharmaceutical Cleaning Validation Services
Pharmaceutical Equipment Validation Services
Others
Segment by Application
Pharmaceutical Companies
Biotechnological Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Validation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pharmaceutical Validation Services market was valued at US$ 89 million in 2023 and is anticipated to reach US$ 133.6 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Validation Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Validation Services.
Report Scope
The Pharmaceutical Validation Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Validation Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Validation Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbor Group
ATS Global
Catalent
CRS Pharma Solutions
Eurofins Scientific
Körber Pharma
Merck Millipore
MTS (Meissner Technical Services)
Navitas pharma READY
PharmOut
SGS
Sigma-Aldrich
SL Controls
Transcat
Segment by Type
Pharmaceutical Cleaning Validation Services
Pharmaceutical Equipment Validation Services
Others
Segment by Application
Pharmaceutical Companies
Biotechnological Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Validation Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Validation Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmaceutical Cleaning Validation Services
1.2.3 Pharmaceutical Equipment Validation Services
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pharmaceutical Validation Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biotechnological Companies
1.3.4 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Validation Services Market Perspective (2019-2030)
2.2 Pharmaceutical Validation Services Growth Trends by Region
2.2.1 Global Pharmaceutical Validation Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Validation Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Validation Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Validation Services Market Dynamics
2.3.1 Pharmaceutical Validation Services Industry Trends
2.3.2 Pharmaceutical Validation Services Market Drivers
2.3.3 Pharmaceutical Validation Services Market Challenges
2.3.4 Pharmaceutical Validation Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Validation Services Players by Revenue
3.1.1 Global Top Pharmaceutical Validation Services Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Validation Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Validation Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Validation Services Revenue
3.4 Global Pharmaceutical Validation Services Market Concentration Ratio
3.4.1 Global Pharmaceutical Validation Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Validation Services Revenue in 2023
3.5 Pharmaceutical Validation Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Validation Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical Validation Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Validation Services Breakdown Data by Type
4.1 Global Pharmaceutical Validation Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Validation Services Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Validation Services Breakdown Data by Application
5.1 Global Pharmaceutical Validation Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Validation Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Validation Services Market Size (2019-2030)
6.2 North America Pharmaceutical Validation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Validation Services Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Validation Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Validation Services Market Size (2019-2030)
7.2 Europe Pharmaceutical Validation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Validation Services Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Validation Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Validation Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Validation Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Validation Services Market Size (2019-2030)
9.2 Latin America Pharmaceutical Validation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Validation Services Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Validation Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Validation Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Validation Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arbor Group
11.1.1 Arbor Group Company Detail
11.1.2 Arbor Group Business Overview
11.1.3 Arbor Group Pharmaceutical Validation Services Introduction
11.1.4 Arbor Group Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.1.5 Arbor Group Recent Development
11.2 ATS Global
11.2.1 ATS Global Company Detail
11.2.2 ATS Global Business Overview
11.2.3 ATS Global Pharmaceutical Validation Services Introduction
11.2.4 ATS Global Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.2.5 ATS Global Recent Development
11.3 Catalent
11.3.1 Catalent Company Detail
11.3.2 Catalent Business Overview
11.3.3 Catalent Pharmaceutical Validation Services Introduction
11.3.4 Catalent Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 CRS Pharma Solutions
11.4.1 CRS Pharma Solutions Company Detail
11.4.2 CRS Pharma Solutions Business Overview
11.4.3 CRS Pharma Solutions Pharmaceutical Validation Services Introduction
11.4.4 CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.4.5 CRS Pharma Solutions Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmaceutical Validation Services Introduction
11.5.4 Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.5.5 Eurofins Scientific Recent Development
11.6 Körber Pharma
11.6.1 Körber Pharma Company Detail
11.6.2 Körber Pharma Business Overview
11.6.3 Körber Pharma Pharmaceutical Validation Services Introduction
11.6.4 Körber Pharma Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.6.5 Körber Pharma Recent Development
11.7 Merck Millipore
11.7.1 Merck Millipore Company Detail
11.7.2 Merck Millipore Business Overview
11.7.3 Merck Millipore Pharmaceutical Validation Services Introduction
11.7.4 Merck Millipore Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.7.5 Merck Millipore Recent Development
11.8 MTS (Meissner Technical Services)
11.8.1 MTS (Meissner Technical Services) Company Detail
11.8.2 MTS (Meissner Technical Services) Business Overview
11.8.3 MTS (Meissner Technical Services) Pharmaceutical Validation Services Introduction
11.8.4 MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.8.5 MTS (Meissner Technical Services) Recent Development
11.9 Navitas pharma READY
11.9.1 Navitas pharma READY Company Detail
11.9.2 Navitas pharma READY Business Overview
11.9.3 Navitas pharma READY Pharmaceutical Validation Services Introduction
11.9.4 Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.9.5 Navitas pharma READY Recent Development
11.10 PharmOut
11.10.1 PharmOut Company Detail
11.10.2 PharmOut Business Overview
11.10.3 PharmOut Pharmaceutical Validation Services Introduction
11.10.4 PharmOut Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.10.5 PharmOut Recent Development
11.11 SGS
11.11.1 SGS Company Detail
11.11.2 SGS Business Overview
11.11.3 SGS Pharmaceutical Validation Services Introduction
11.11.4 SGS Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.11.5 SGS Recent Development
11.12 Sigma-Aldrich
11.12.1 Sigma-Aldrich Company Detail
11.12.2 Sigma-Aldrich Business Overview
11.12.3 Sigma-Aldrich Pharmaceutical Validation Services Introduction
11.12.4 Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.12.5 Sigma-Aldrich Recent Development
11.13 SL Controls
11.13.1 SL Controls Company Detail
11.13.2 SL Controls Business Overview
11.13.3 SL Controls Pharmaceutical Validation Services Introduction
11.13.4 SL Controls Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.13.5 SL Controls Recent Development
11.14 Transcat
11.14.1 Transcat Company Detail
11.14.2 Transcat Business Overview
11.14.3 Transcat Pharmaceutical Validation Services Introduction
11.14.4 Transcat Revenue in Pharmaceutical Validation Services Business (2019-2024)
11.14.5 Transcat Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical Validation Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Pharmaceutical Cleaning Validation Services
Table 3. Key Players of Pharmaceutical Equipment Validation Services
Table 4. Key Players of Others
Table 5. Global Pharmaceutical Validation Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pharmaceutical Validation Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pharmaceutical Validation Services Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pharmaceutical Validation Services Market Share by Region (2019-2024)
Table 9. Global Pharmaceutical Validation Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pharmaceutical Validation Services Market Share by Region (2025-2030)
Table 11. Pharmaceutical Validation Services Market Trends
Table 12. Pharmaceutical Validation Services Market Drivers
Table 13. Pharmaceutical Validation Services Market Challenges
Table 14. Pharmaceutical Validation Services Market Restraints
Table 15. Global Pharmaceutical Validation Services Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pharmaceutical Validation Services Market Share by Players (2019-2024)
Table 17. Global Top Pharmaceutical Validation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2023)
Table 18. Ranking of Global Top Pharmaceutical Validation Services Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pharmaceutical Validation Services Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical Validation Services Product Solution and Service
Table 22. Date of Enter into Pharmaceutical Validation Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical Validation Services Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pharmaceutical Validation Services Revenue Market Share by Type (2019-2024)
Table 26. Global Pharmaceutical Validation Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pharmaceutical Validation Services Revenue Market Share by Type (2025-2030)
Table 28. Global Pharmaceutical Validation Services Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pharmaceutical Validation Services Revenue Market Share by Application (2019-2024)
Table 30. Global Pharmaceutical Validation Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pharmaceutical Validation Services Revenue Market Share by Application (2025-2030)
Table 32. North America Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pharmaceutical Validation Services Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pharmaceutical Validation Services Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pharmaceutical Validation Services Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pharmaceutical Validation Services Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pharmaceutical Validation Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pharmaceutical Validation Services Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pharmaceutical Validation Services Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pharmaceutical Validation Services Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pharmaceutical Validation Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pharmaceutical Validation Services Market Size by Country (2025-2030) & (US$ Million)
Table 47. Arbor Group Company Detail
Table 48. Arbor Group Business Overview
Table 49. Arbor Group Pharmaceutical Validation Services Product
Table 50. Arbor Group Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 51. Arbor Group Recent Development
Table 52. ATS Global Company Detail
Table 53. ATS Global Business Overview
Table 54. ATS Global Pharmaceutical Validation Services Product
Table 55. ATS Global Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 56. ATS Global Recent Development
Table 57. Catalent Company Detail
Table 58. Catalent Business Overview
Table 59. Catalent Pharmaceutical Validation Services Product
Table 60. Catalent Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 61. Catalent Recent Development
Table 62. CRS Pharma Solutions Company Detail
Table 63. CRS Pharma Solutions Business Overview
Table 64. CRS Pharma Solutions Pharmaceutical Validation Services Product
Table 65. CRS Pharma Solutions Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 66. CRS Pharma Solutions Recent Development
Table 67. Eurofins Scientific Company Detail
Table 68. Eurofins Scientific Business Overview
Table 69. Eurofins Scientific Pharmaceutical Validation Services Product
Table 70. Eurofins Scientific Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 71. Eurofins Scientific Recent Development
Table 72. Körber Pharma Company Detail
Table 73. Körber Pharma Business Overview
Table 74. Körber Pharma Pharmaceutical Validation Services Product
Table 75. Körber Pharma Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 76. Körber Pharma Recent Development
Table 77. Merck Millipore Company Detail
Table 78. Merck Millipore Business Overview
Table 79. Merck Millipore Pharmaceutical Validation Services Product
Table 80. Merck Millipore Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 81. Merck Millipore Recent Development
Table 82. MTS (Meissner Technical Services) Company Detail
Table 83. MTS (Meissner Technical Services) Business Overview
Table 84. MTS (Meissner Technical Services) Pharmaceutical Validation Services Product
Table 85. MTS (Meissner Technical Services) Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 86. MTS (Meissner Technical Services) Recent Development
Table 87. Navitas pharma READY Company Detail
Table 88. Navitas pharma READY Business Overview
Table 89. Navitas pharma READY Pharmaceutical Validation Services Product
Table 90. Navitas pharma READY Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 91. Navitas pharma READY Recent Development
Table 92. PharmOut Company Detail
Table 93. PharmOut Business Overview
Table 94. PharmOut Pharmaceutical Validation Services Product
Table 95. PharmOut Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 96. PharmOut Recent Development
Table 97. SGS Company Detail
Table 98. SGS Business Overview
Table 99. SGS Pharmaceutical Validation Services Product
Table 100. SGS Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 101. SGS Recent Development
Table 102. Sigma-Aldrich Company Detail
Table 103. Sigma-Aldrich Business Overview
Table 104. Sigma-Aldrich Pharmaceutical Validation Services Product
Table 105. Sigma-Aldrich Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 106. Sigma-Aldrich Recent Development
Table 107. SL Controls Company Detail
Table 108. SL Controls Business Overview
Table 109. SL Controls Pharmaceutical Validation Services Product
Table 110. SL Controls Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 111. SL Controls Recent Development
Table 112. Transcat Company Detail
Table 113. Transcat Business Overview
Table 114. Transcat Pharmaceutical Validation Services Product
Table 115. Transcat Revenue in Pharmaceutical Validation Services Business (2019-2024) & (US$ Million)
Table 116. Transcat Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Validation Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical Validation Services Market Share by Type: 2023 VS 2030
Figure 3. Pharmaceutical Cleaning Validation Services Features
Figure 4. Pharmaceutical Equipment Validation Services Features
Figure 5. Others Features
Figure 6. Global Pharmaceutical Validation Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pharmaceutical Validation Services Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Biotechnological Companies Case Studies
Figure 10. Academic and Research Institutes Case Studies
Figure 11. Pharmaceutical Validation Services Report Years Considered
Figure 12. Global Pharmaceutical Validation Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pharmaceutical Validation Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pharmaceutical Validation Services Market Share by Region: 2023 VS 2030
Figure 15. Global Pharmaceutical Validation Services Market Share by Players in 2023
Figure 16. Global Top Pharmaceutical Validation Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Validation Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Validation Services Revenue in 2023
Figure 18. North America Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pharmaceutical Validation Services Market Share by Country (2019-2030)
Figure 20. United States Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pharmaceutical Validation Services Market Share by Country (2019-2030)
Figure 24. Germany Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical Validation Services Market Share by Region (2019-2030)
Figure 32. China Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pharmaceutical Validation Services Market Share by Country (2019-2030)
Figure 40. Mexico Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical Validation Services Market Share by Country (2019-2030)
Figure 44. Turkey Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pharmaceutical Validation Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Arbor Group Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 47. ATS Global Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 48. Catalent Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 49. CRS Pharma Solutions Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 50. Eurofins Scientific Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 51. Körber Pharma Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 52. Merck Millipore Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 53. MTS (Meissner Technical Services) Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 54. Navitas pharma READY Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 55. PharmOut Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 56. SGS Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 57. Sigma-Aldrich Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 58. SL Controls Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 59. Transcat Revenue Growth Rate in Pharmaceutical Validation Services Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
